期刊文献+

非上呼吸消化道结外NK/T细胞淋巴瘤的不良预后因素分析

Analysis of adverse prognostic factors of non-upper aerodigestive tract extranodal NK/T-cell lymphoma
下载PDF
导出
摘要 目的:分析非上呼吸消化道来源的结外NK/T细胞淋巴瘤(non-upper aerodigestive tract extranodal NK/T-cell lymphoma,NUAT-ENKTCL)的不良预后因素。方法:回顾性分析郑州大学第一附属医院2011年1月至2015年12月收治的20例NUAT-NKTCL患者临床资料,采用Kaplan-Meier法进行生存分析,应用Log-Rank法检验对EBER表达、年龄、性别、乳酸脱氢酶(lactic dehydrogenase,LDH)水平和治疗前外周血EBV-DNA拷贝数等进行单因素分析。结果:20例患者中,男女比为13∶7。中位年龄为39(12~66)岁,其中≥60岁3例(15%),<60岁17例(85%)。Ann Arbor分期:Ⅰ、Ⅱ期8例(40%),Ⅲ、Ⅳ期12例(60%)。LDH水平升高12例(60%)。治疗前外周血EBV-DNA拷贝数增加11例(55%)。病变组织中EBER(+)13例(65%)。患者截至随访时间死亡4例,生存16例,中位总生存期(median overall survival,mOS)为15.4个月,中位无进展生存期(median progression free survival,mPFS)为8个月。完全缓解(complete response,CR)11例(55%),部分缓解(partial response,PR)5例(25%),客观缓解率(objective response rate,ORR)为80%。单因素分析显示年龄与预后呈显著相关性。结论:EBER的表达并不影响NUAT-ENKTCL患者的预后,年龄≥60岁患者预后较差。 Objective:To investigate the prognostic factors of non-upper aerodigestive tract extranodal NK/T-cell lymphoma(NUATNKTCL).Methods:Samples from twenty patients with NUAT-NKTCL,who were treated in The First Affiliated Hospital of Zhengzhou University between January 2011 and December 2015,were collected.The overall survival(OS)and progression-free survival(PFS)time of these patients were estimated by the Kaplan-Meier method.Through the log-rank test,the survival curves were compared among EBER expression,age,lactate dehydrogenase(LDH)level,EBV-DNA copies,and gender.Results:The male-female ratio of patients was 13:7.The median age was 39 years(range 12-66),with 3 patients above 60 years(15%)and the others below 60 years(85%).Forty percent of the patients were Ann-Arbor stageⅠ/Ⅱand 60%of them were Ann-Arbor stageⅢ/Ⅳ.Twelve patients(60%)had a high level of LDH.Eleven patients had a high level of EBV-DNA copies in peripheral blood(55%)before treatment.Thirteen patients were EBER positive.Among the 20 patients,4 patients died and 16 survived.The median OS was 15.4 months,and the median PFS was 8 months.Eleven patients received CR,5 achieved PR while the ORR was 80%.The Log-rank test showed a significant association between age and prognosis(P=0.001).Conclusions:There was no correlation between EBER expression and prognosis of NUAT-NKTCL.Patients over 60 years of age had a poor prognosis.
作者 马咪静 杨珍珍 尹美凤 杨万秋 丁梦杰 朱利楠 董萌 张蕾 李鑫 孙振昌 李玲 王冠男 张旭东 张明智 陈清江 Mijing Ma;Zhenzhen Yang;Meifeng Yin;Wanqiu Yang;Mengjie Ding;Linan Zhu;Meng Dong;Lei Zhang;Xin Li;Zhenchang Sun;Ling Li;Guannan Wang;Xudong Zhang;Mingzhi Zhang;Qingjiang Chen(Department of Oncology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Lymphoma Diagnosis and Treatment Center of Henan Province,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Third Affiliated Hospital of Xinxiang Medical College,Xinxiang 453000,China;Department of Pathology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China)
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2018年第18期939-942,共4页 Chinese Journal of Clinical Oncology
基金 本文课题受国家自然科学基金面上项目(编号:81470364)资助。
关键词 非上呼吸消化道NK/T细胞淋巴瘤 EBER表达 生存分析 预后 non-upper aerodigestive tract extranodal NK/T-cell lymphoma(NUAT-NKTCL) EBER expression survival analysis prognosis
  • 相关文献

参考文献2

二级参考文献11

  • 1Sabattini E , Bacci F , Sagramoso C, et al. WHOclassification of tumours of haematopoietic andlymphoid tissues in 2008 : an overview [ J ].Pathologica,2010, 102(3):83-87.
  • 2Alizadeh AA,Eisen MB , Davis RE,et al. Distincttypes of diffuse large B-cell lymphoma identified bygene expression profiling [ J ]. Nature, 2000,403(6769) :503-511.
  • 3Hans CP , Weisenburger DD,Greiner TC,et al.Confirmation of the molecular classification of diffuselarge B-cell lymphoma by immunohistochemistryusing a tissue microarray [ J]. Blood,2004,103 ( 1 ):275-282.
  • 4Au WY,Horsman DE,Gascoyne RD,et al. Thespectrum of lymphoma with 8q24 aberrations : aclinical,pathological and cytogenetic study of 87consecutive cases [ J ]. Leuk Lymphoma, 2004,45(3):519-528.
  • 5Sehn LH, Berry B, Chhanabhai M, et al. The revisedinternational prognostic index ( R-IPI) is a betterpredictor of outcome than the standard IPI for patientswith diffuse large B-cell lymphoma treated with R-CHOP[J]. Blood,2007,109(5) :1857-1861.
  • 6Yoon SO,Jeon YK,Paik JH,et al. MYC translocationand an increased copy number predict poor prognosisin adult diffuse large B-cell lymphoma ( DLBCL),especially in germinal centre-like B cell ( GCB) type[J]. Histopathology ,2008 ,53 (2) :205-217.
  • 7Savage KJ, Johnson NA, Ben-Neriah S, et al. MYCgene rearrangements are associated with a poorprognosis in diffuse large B-cell lymphoma patientstreated with R-CHOP chemotherapy[ J]. Blood,2009,114(17) :3533-3537.
  • 8Snuderl M , Kolman OK, Chen YB , et al. B-celllymphomas with concurrent IGH-BCL2 and MYCrearrangements are aggressive neoplasms with clinicaland pathologic features distinct from Burkittlymphoma and diffuse large B-cell lymphoma[ J]. AmJ Surg Pathol,2010,34(3) :327-340.
  • 9Ninan MJ, Wadhwa PD,Gupta P,et al. Prognosticationof diffuse large B-cell lymphoma in the rituximab era[J]. Leuk Lymphoma,2011 ,52(3) :360-373.
  • 10He L, He X, Lim LP, et al. A microRNA componentof the p53 tumour suppressor network [ J ]. Nature,2007,447(7148) :1130-1134.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部